Federal grants to University of Texas Medical Branch at Galveston
University of Texas Medical Branch at Galveston in Galveston, Texas received $612 million in federal grants from fiscal 2021 to 2025, across 362 awards. Its largest program was Allergy and Infectious Diseases Research, with $320 million. In fiscal 2025 it was awarded $92.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$612 million
- Awards362
- Awarded in FY 2025$92.2 million
- Largest award$75.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 174 | $104 million |
| FY 2022 | 180 | $164 million |
| FY 2023 | 176 | $120 million |
| FY 2024 | 166 | $132 million |
| FY 2025 | 156 | $92.2 million |
Programs that fund University of Texas Medical Branch at Galveston
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 117 | $320 million |
| Aging Research | 44 | $58.6 million |
| Drug Use and Addiction Research Programs | 14 | $26.5 million |
| National Center for Advancing Translational Sciences | 7 | $26.0 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 18 | $21.4 million |
| Biomedical Research and Research Training | 22 | $19.5 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 13 | $17.2 million |
| Mental Health Research Grants | 8 | $14.5 million |
| Trans-NIH Research Support | 8 | $11.6 million |
| Child Health and Human Development Extramural Research | 13 | $10.7 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 329 | $587 million |
| Department of Defense | 10 | $10.4 million |
| National Aeronautics and Space Administration | 4 | $5.2 million |
| Department of Education | 2 | $4.7 million |
| Department of Agriculture | 4 | $1.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Utmb-novartis alliance for pandemic preparedness - overall – abstract pandemic prevention and preparedness is a major scientific and societal priority that requires sustained and forward looking investments across governmental, non-governmental, academic and private sectors to develop an arsenal of | Allergy and Infectious Diseases Research | May 16, 2022 | $75.0 million |
| National biocontainment laboratories (NBLS) operations support | Allergy and Infectious Diseases Research | January 13, 2021 | $57.5 million |
| Paramyxoviridae and bunyavirales vaccines and antibodies center (PABVAX) - project summary/abstract - overall emerging and reemerging pathogenic rna viruses represent continuous infectious disease and pandemic threats to public health. Among the many groups of these types of pathogens are viral zoon | Allergy and Infectious Diseases Research | July 30, 2024 | $46.4 million |
| Advancement of vaccines and treatments for ebola and marburg virus infections | Allergy and Infectious Diseases Research | November 16, 2020 | $19.9 million |
| Ctsa supplement | National Center for Advancing Translational Sciences | December 8, 2020 | $16.0 million |
| Molecular mechanisms of the dysregulated immune response to ebola virus - overall: project summary/abstract the central hypothesis of the proposed P01 program is that ebola virus infection leads to cell-type specific transcriptional, posttranscriptional, and posttranslational alterations that create | Allergy and Infectious Diseases Research | April 16, 2021 | $11.3 million |
| Interdisciplinary research network on biologically active tau aggregate polymorphs from alzheimer's disease and related dementias - project summary tau aggregation is a shared pathology of alzheimer's disease and related dementias known as tauopathies. Because each disorder develops a unique combina | Aging Research | June 23, 2021 | $7.8 million |
| Understanding the mechanistic, neurophysiological, and antinociceptive effects of transcutaneous auricular neurostimulation for treatment of chronic pain - project summary/abstract despite growing urgency to transition many chronic pain patients off prescription opioids, there is limited evidentiary | Drug Use and Addiction Research Programs | September 12, 2022 | $7.1 million |
| West african center for emerging infectious diseases | Allergy and Infectious Diseases Research | June 11, 2021 | $6.7 million |
| Coordinating research on emerging arboviral threats encoing the neotropics (create-neo) | Allergy and Infectious Diseases Research | May 26, 2021 | $6.4 million |
Questions people ask
How much federal grant money does University of Texas Medical Branch at Galveston get?
$612 million in 362 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives University of Texas Medical Branch at Galveston the most?
The Department of Health and Human Services, with $587 million in 329 awards. The Department of Defense and the National Aeronautics and Space Administration follow.
What is University of Texas Medical Branch at Galveston's largest federal grant?
$75.0 million under Allergy and Infectious Diseases Research, with its first action in the period on May 16, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund University of Texas Medical Branch at Galveston?
Its largest are Allergy and Infectious Diseases Research, Aging Research and Drug Use and Addiction Research Programs.
Other grant recipients in Galveston
- Texas a & M University at Galveston
- Galveston College
- Galveston Housing Authority
- City of Galveston
- City of Galveston
- The Children's Center, Inc
- The Board of Trustees of the Galveston Wharves
- Galveston Independent School District
Largest federal grant recipients in Texas · Federal grants in Texas